Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 23;107(7):1825–1832. doi: 10.1210/clinem/dgac256

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

PMC Copyright notice

Figure 3. — Serum biomarkers in T1D patients. Serum levels of 6 candidate protein biomarkers: A, OPN; B, IL1-RA; C, YKL-40; D, M-CSF; E, TRAIL; and F, SAA in newly diagnosed children with T1D, T2D, and age-matched healthy controls (combined the results from the first and the second group of participants). The y-axis indicates log-10 transformation of the counts per second (cps) values from the plate counting machine. IL-1RA, interleukin 1 receptor antagonist; M-CSF, macrophage colony-stimulating factor 1; OPN, osteopontin; SAA, serum amyloid A1; T1D, type 1 diabetes; T2D, type 2 diabetes; TRAIL, tumor necrosis factor superfamily member 10; YKL-40, chitinase 3-like 1.